Key Takeaways
- • CVC Capital Partners is exploring a sale of Arthea (formerly PDC Brands), owner of personal care brands including Dr Teal's, Bodycology, Body Fantasies, BOD Man, and Cantu, at an estimated $2 billion valuation.
- • CVC acquired the business for $1.43 billion in 2017 from Yellow Wood Partners, representing a potential 40% value appreciation over nine years.
- • Moelis and William Blair have been appointed as financial advisors; discussions remain in early stages and may not materialize into a completed transaction.
- • Arthea rebranded last month and simultaneously launched Sunryz, a new body care line targeting the tween demographic, signaling continued portfolio expansion.
- • A disposal would follow a series of substantial consumer and personal care sector M&A activity, including L'Oréal's $4.7 billion acquisition of Kering's beauty division and Henkel's $1.4 billion purchase of Olaplex.
Summary
CVC Capital Partners is weighing a strategic exit from personal care company Arthea, the owner of multiple established consumer brands, in a potential transaction valued at approximately $2 billion. According to Reuters, CVC has engaged investment banking advisors Moelis and William Blair to explore a sale of the privately held platform. The transaction remains preliminary, and sources cautioned that discussions are at an early stage with no certainty of completion.
Arthea's portfolio comprises established consumer brands spanning bath and body, fragrance, and hair care categories. The company owns Dr Teal's, Bodycology, Body Fantasies, BOD Man, and Cantu, with distribution across more than 80 countries. The business, founded in 1981 and headquartered in White Plains, New York, rebranded from PDC Brands to Arthea last month—a name change intended to emphasize its personal care and wellbeing positioning. Concurrent with the rebrand, Arthea unveiled Sunryz, a new body care brand targeting the tween market segment.
CVC's acquisition of PDC Brands from Yellow Wood Partners in 2017 was valued at $1.43 billion. A sale at the reported $2 billion valuation would represent meaningful appreciation of approximately 40% over the nine-year holding period. The potential disposal reflects broader private equity appetite for consumer asset exits, particularly as the sector experiences consolidation. Recent comparable transactions underscore market activity: L'Oréal paid $4.7 billion for Kering's beauty division, while Henkel acquired hair care brand Olaplex for $1.4 billion, both transactions completed this year. These precedent valuations provide contextual support for Arthea's estimated $2 billion price range.
Arthea's portfolio comprises established consumer brands spanning bath and body, fragrance, and hair care categories. The company owns Dr Teal's, Bodycology, Body Fantasies, BOD Man, and Cantu, with distribution across more than 80 countries. The business, founded in 1981 and headquartered in White Plains, New York, rebranded from PDC Brands to Arthea last month—a name change intended to emphasize its personal care and wellbeing positioning. Concurrent with the rebrand, Arthea unveiled Sunryz, a new body care brand targeting the tween market segment.
CVC's acquisition of PDC Brands from Yellow Wood Partners in 2017 was valued at $1.43 billion. A sale at the reported $2 billion valuation would represent meaningful appreciation of approximately 40% over the nine-year holding period. The potential disposal reflects broader private equity appetite for consumer asset exits, particularly as the sector experiences consolidation. Recent comparable transactions underscore market activity: L'Oréal paid $4.7 billion for Kering's beauty division, while Henkel acquired hair care brand Olaplex for $1.4 billion, both transactions completed this year. These precedent valuations provide contextual support for Arthea's estimated $2 billion price range.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.